Cargando…

Immune Suppression in Pregnancy and Cancer: Parallels and Insights

Immune system has evolved to maintain homeostatic balance between effector and regulatory immunity, which is critical to both elicit an adequate protective response to fight pathogens and disease, such as cancer, and to prevent damage to healthy tissues. Transient immune suppression can occur under...

Descripción completa

Detalles Bibliográficos
Autor principal: Kareva, Irina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191218/
https://www.ncbi.nlm.nih.gov/pubmed/32353791
http://dx.doi.org/10.1016/j.tranon.2020.100759
_version_ 1783527820982484992
author Kareva, Irina
author_facet Kareva, Irina
author_sort Kareva, Irina
collection PubMed
description Immune system has evolved to maintain homeostatic balance between effector and regulatory immunity, which is critical to both elicit an adequate protective response to fight pathogens and disease, such as cancer, and to prevent damage to healthy tissues. Transient immune suppression can occur under normal physiological conditions, such as during wound healing to enable repair of normal tissue, or for more extended periods of time during fetal development, where the balance is shifted towards regulatory immunity to prevent fetal rejection. Interestingly, tumors can exhibit patterns of immune suppression very similar to those observed during fetal development. Here some of the key aspects of normal patterns of immune suppression during pregnancy are reviewed, followed by a discussion of parallels that exist with tumor-related immune suppression and consequent potential therapeutic implications.
format Online
Article
Text
id pubmed-7191218
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Neoplasia Press
record_format MEDLINE/PubMed
spelling pubmed-71912182020-05-04 Immune Suppression in Pregnancy and Cancer: Parallels and Insights Kareva, Irina Transl Oncol Review article Immune system has evolved to maintain homeostatic balance between effector and regulatory immunity, which is critical to both elicit an adequate protective response to fight pathogens and disease, such as cancer, and to prevent damage to healthy tissues. Transient immune suppression can occur under normal physiological conditions, such as during wound healing to enable repair of normal tissue, or for more extended periods of time during fetal development, where the balance is shifted towards regulatory immunity to prevent fetal rejection. Interestingly, tumors can exhibit patterns of immune suppression very similar to those observed during fetal development. Here some of the key aspects of normal patterns of immune suppression during pregnancy are reviewed, followed by a discussion of parallels that exist with tumor-related immune suppression and consequent potential therapeutic implications. Neoplasia Press 2020-04-27 /pmc/articles/PMC7191218/ /pubmed/32353791 http://dx.doi.org/10.1016/j.tranon.2020.100759 Text en © 2020 Published by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review article
Kareva, Irina
Immune Suppression in Pregnancy and Cancer: Parallels and Insights
title Immune Suppression in Pregnancy and Cancer: Parallels and Insights
title_full Immune Suppression in Pregnancy and Cancer: Parallels and Insights
title_fullStr Immune Suppression in Pregnancy and Cancer: Parallels and Insights
title_full_unstemmed Immune Suppression in Pregnancy and Cancer: Parallels and Insights
title_short Immune Suppression in Pregnancy and Cancer: Parallels and Insights
title_sort immune suppression in pregnancy and cancer: parallels and insights
topic Review article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191218/
https://www.ncbi.nlm.nih.gov/pubmed/32353791
http://dx.doi.org/10.1016/j.tranon.2020.100759
work_keys_str_mv AT karevairina immunesuppressioninpregnancyandcancerparallelsandinsights